Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data - Raja, F.A.; Counsell, N.; Colombo, N.; Pfisterer, J.; du Bois, A.; Parmar, M.K.; Vergote, I.B.; Gonzalez-Martin, A.; Alberts, D.S.; Plante, M.; Torri, V.; Ledermann, J.A. (Annals of oncology, 2013)
Keywords: Antineoplastic agents; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Carboplatin - administration & dosage; Cisplatin - administration & dosage; Disease-Free Survival; Female; Female genital diseases; Gynecology. Andrology. Obstetrics; Humans; IPD meta-analysis; Kaplan-Meier Estimate; Medical sciences; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Neoplasm Recurrence, Local - drug therapy; Neoplasm Recurrence, Local - mortality; Ovarian Neoplasms - drug therapy; Ovarian Neoplasms - mortality; Pharmacology. Drug treatments; Randomized Controlled Trials as Topic; recurrent ovarian cancer; Treatment Outcome; Tumors; IPD meta-analysis; recurrent ovarian cancer; Human; Drug combination; Relapse; Ovary cancer; Malignant tumor; Female genital diseases; Metaanalysis; Ovarian diseases; Platinum; Combined treatment; Comparative study; Cancer